Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Characterization of systemic immunosuppression by IDH mutant glioma small extracellular vesicles

Neuro-Oncology(2021)10.1093/neuonc/noab153Source: DataRank Database

Characterization of systemic immunosuppression by IDH mutant glioma small extracellular vesicles is a research paper published in Neuro-Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 56 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access56 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 6.29)OA: greenTopics (29)Linked Datasets (25)DataCite Reuse (25)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Aparna Rao ORCID,Poorva Sandlesh ORCID,Saigopalakrishna S. Yerneni ORCID,Alexander D Swain,Kristin M. Bullock

Live enrichment

PubMed:34254643 PMC:PMC8804898 OpenAlex:https://openalex.org/W3179450640

National Institutes of Health

Grant: U01-DE029759

NIDCR NIH HHS

Grant: U01 DE029759

German National Academy of Sciences

FWCI

6.29

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8804898

publisherhttp://academic.oup.com/neuro-oncology/advance-article-pdf/doi/10.1093/neuonc/noab153/39627196/noab153.pdf

publisherhttps://academic.oup.com/neuro-oncology/article-pdf/24/2/197/42334536/noab153.pdf

journalhttps://doi.org/10.1093/neuonc/noab153

Fields of Study

Glioma Diagnosis and TreatmentExtracellular vesicles in diseaseImmune cells in cancer

MeSH Terms

Extracellular VesiclesAnimalsBrain NeoplasmsGliomaHumansImmune ToleranceIsocitrate DehydrogenaseMutationTissue DistributionMiceTumor Microenvironment

Keywords

GliomaImmune systemBiologyTumor microenvironmentCancer researchBrain tumorImmunosuppressionIsocitrate dehydrogenasePathologyImmunologyMedicineimmune suppressionExosomesIsocitrate Dehydrogenase (Idh)Small Extracellular Vesicles

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 14 of Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma

10.6084/m9.figshare.23896126.v1figshare

Additional file 15 of Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma

10.6084/m9.figshare.23896129.v1figshare

Additional file 12 of Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma

10.6084/m9.figshare.23896120.v1figshare

Additional file 13 of Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma

10.6084/m9.figshare.23896123.v1figshare

Additional file 15 of Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma

10.6084/m9.figshare.23896129figshare

Additional file 13 of Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma

10.6084/m9.figshare.23896123figshare

Additional file 11 of Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma

10.6084/m9.figshare.23896117.v1figshare

Additional file 12 of Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma

10.6084/m9.figshare.23896120figshare

Additional file 14 of Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma

10.6084/m9.figshare.23896126figshare

Additional file 7 of Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma

10.6084/m9.figshare.23896105figshare

Additional file 8 of Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma

10.6084/m9.figshare.23896108figshare

Additional file 10 of Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma

10.6084/m9.figshare.23896114figshare

Additional file 9 of Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma

10.6084/m9.figshare.23896111figshare

Additional file 9 of Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma

10.6084/m9.figshare.23896111.v1figshare

Additional file 10 of Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma

10.6084/m9.figshare.23896114.v1figshare

Additional file 11 of Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma

10.6084/m9.figshare.23896117figshare

Additional file 7 of Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma

10.6084/m9.figshare.23896105.v1figshare

Additional file 8 of Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma

10.6084/m9.figshare.23896108.v1figshare

Additional file 3 of Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma

10.6084/m9.figshare.23896093.v1figshare

Additional file 3 of Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma

10.6084/m9.figshare.23896093figshare